Literature DB >> 27497840

Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well?

Michael G Wheaton1, Hanga Galfalvy2, Shari A Steinman2, Melanie M Wall2, Edna B Foa3, H Blair Simpson4.   

Abstract

Exposure and response prevention (EX/RP) is an evidence-based treatment for obsessive-compulsive disorder (OCD), yet not all patients achieve wellness with EX/RP. The degree to which patients adhere to EX/RP procedures outside of sessions has been found to predict therapy outcomes, including who achieves post-treatment wellness. We sought to investigate which components of treatment adherence most relate to outcome and to develop adherence benchmarks to identify who does and does not become well to provide clinicians with prognostic tools. Adherence data came from 37 adult patients with DSM-IV OCD who received 17 sessions of EX/RP as part of a randomized controlled trial of augmentation strategies for incomplete response to serotonin reuptake inhibitors (SRIs). Therapists rated between-session patient adherence at each exposure session by quantifying: 1) the quantity of homework exposures attempted; 2) the quality of attempted exposures; and 3) the degree of success with response prevention. Each adherence item significantly correlated with post-treatment OCD severity. Success with response prevention proved particularly strongly linked to therapy outcome. Time course analysis of this item accurately identified, relatively early in treatment, who would achieve post-treatment wellness. These data provide an efficient method for differentiating between those patients who will and will not achieve wellness after EX/RP augmentation of SRIs. Limitations and clinical implications of the current findings are discussed.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Exposure and response prevention; Obsessive-compulsive disorder; Patient adherence

Mesh:

Substances:

Year:  2016        PMID: 27497840      PMCID: PMC5031484          DOI: 10.1016/j.brat.2016.07.010

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  28 in total

1.  Development of a patient adherence scale for exposure and response prevention therapy.

Authors:  Helen Blair Simpson; Michael Maher; Jessica R Page; Carly J Gibbons; Martin E Franklin; Edna B Foa
Journal:  Behav Ther       Date:  2009-05-29

Review 2.  Optimizing inhibitory learning during exposure therapy.

Authors:  Michelle G Craske; Katharina Kircanski; Moriel Zelikowsky; Jayson Mystkowski; Najwa Chowdhury; Aaron Baker
Journal:  Behav Res Ther       Date:  2007-10-07

3.  Maximizing exposure therapy: an inhibitory learning approach.

Authors:  Michelle G Craske; Michael Treanor; Christopher C Conway; Tomislav Zbozinek; Bram Vervliet
Journal:  Behav Res Ther       Date:  2014-05-09

4.  Response versus remission in obsessive-compulsive disorder.

Authors:  Helen Blair Simpson; Jonathan D Huppert; Eva Petkova; Edna B Foa; Michael R Liebowitz
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

5.  Differential effects of exposure and response prevention in obsessive-compulsive washers.

Authors:  E B Foa; G Steketee; J B Milby
Journal:  J Consult Clin Psychol       Date:  1980-02

6.  Moderators and predictors of response to cognitive-behavioral therapy augmentation of pharmacotherapy in obsessive-compulsive disorder.

Authors:  M J Maher; J D Huppert; H Chen; N Duan; E B Foa; M R Liebowitz; H B Simpson
Journal:  Psychol Med       Date:  2010-04-26       Impact factor: 7.723

7.  Treatment compliance and outcome in obsessive-compulsive disorder.

Authors:  Jonathan S Abramowitz; Martin E Franklin; Lori A Zoellner; Corrie L DiBernardo
Journal:  Behav Modif       Date:  2002-09

8.  Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial.

Authors:  David F Tolin; Nicholas Maltby; Gretchen J Diefenbach; Scott E Hannan; Patrick Worhunsky
Journal:  J Clin Psychiatry       Date:  2004-07       Impact factor: 4.384

9.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

10.  Treatment response, symptom remission, and wellness in obsessive-compulsive disorder.

Authors:  Samantha G Farris; Carmen P McLean; Page E Van Meter; Helen Blair Simpson; Edna B Foa
Journal:  J Clin Psychiatry       Date:  2013-07       Impact factor: 4.384

View more
  10 in total

1.  Long-term Outcomes of Intensive Inpatient Care for Severe, Resistant Obsessive-Compulsive Disorder: Résultats à long terme de soins intensifs à des patients hospitalisés pour un trouble obsessionnel-compulsif grave et résistant.

Authors:  Srinivas Balachander; Aakash Bajaj; Nandita Hazari; Ajay Kumar; Nitin Anand; M Manjula; Paulomi M Sudhir; Anish V Cherian; Janardhanan C Narayanaswamy; T S Jaisoorya; Suresh Bada Math; Thennarasu Kandavel; Shyam Sundar Arumugham; Y C Janardhan Reddy
Journal:  Can J Psychiatry       Date:  2020-05-26       Impact factor: 4.356

2.  Innovations in the Delivery of Exposure and Response Prevention for Obsessive-Compulsive Disorder.

Authors:  Sapana R Patel; Jonathan Comer; Helen Blair Simpson
Journal:  Curr Top Behav Neurosci       Date:  2021

3.  Behavioral avoidance predicts treatment outcome with exposure and response prevention for obsessive-compulsive disorder.

Authors:  Michael G Wheaton; Marina Gershkovich; Thea Gallagher; Edna B Foa; H Blair Simpson
Journal:  Depress Anxiety       Date:  2018-02-02       Impact factor: 6.505

Review 4.  Obsessive-compulsive disorder.

Authors:  Dan J Stein; Daniel L C Costa; Christine Lochner; Euripedes C Miguel; Y C Janardhan Reddy; Roseli G Shavitt; Odile A van den Heuvel; H Blair Simpson
Journal:  Nat Rev Dis Primers       Date:  2019-08-01       Impact factor: 52.329

5.  Homework adherence predicts therapeutic improvement from behavior therapy in Tourette's disorder.

Authors:  Joey K-Y Essoe; Emily J Ricketts; Kesley A Ramsey; John Piacentini; Douglas W Woods; Alan L Peterson; Lawrence Scahill; Sabine Wilhelm; John T Walkup; Joseph F McGuire
Journal:  Behav Res Ther       Date:  2021-03-13

6.  Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.

Authors:  Helen B Simpson; Edna B Foa; Michael G Wheaton; Thea Gallagher; Marina Gershkovich; Andrew B Schmidt; Jonathan D Huppert; Raphael B Campeas; Patricia A Imms; Shawn P Cahill; Christina DiChiara; Steven D Tsao; Anthony C Puliafico; Daniel Chazin; Anu Asnaani; Kelly Moore; Jeremy Tyler; Shari A Steinman; Arturo Sanchez-LaCay; Sandy Capaldi; Ivar Snorrason; Elizabeth Turk-Karan; Donna Vermes; Eyal Kalanthroff; Anthony Pinto; Chang-Gyu Hahn; Bin Xu; Page E Van Meter; Martha Katechis; Jennifer Scodes; Yuanjia Wang
Journal:  Behav Res Ther       Date:  2021-05-29

Review 7.  Exposure and Response Prevention in the Treatment of Obsessive-Compulsive Disorder: Current Perspectives.

Authors:  Clara Law; Christina L Boisseau
Journal:  Psychol Res Behav Manag       Date:  2019-12-24

8.  Mechanisms of exposure and response prevention in obsessive-compulsive disorder: effects of habituation and expectancy violation on short-term outcome in cognitive behavioral therapy.

Authors:  Björn Elsner; Tanja Jacobi; Eva Kischkel; Daniel Schulze; Benedikt Reuter
Journal:  BMC Psychiatry       Date:  2022-01-27       Impact factor: 3.630

9.  Treatment Adherence as Predictor of Outcome in Concentrated Exposure Treatment for Obsessive-Compulsive Disorder.

Authors:  Kristian Tjelle; Håvard Berg Opstad; Stian Solem; Gunvor Launes; Bjarne Hansen; Gerd Kvale; Kristen Hagen
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

10.  Effectiveness of a Participatory and Interactive Virtual Reality Intervention in Patients With Social Anxiety Disorder: Longitudinal Questionnaire Study.

Authors:  Hyun-Jin Kim; Seulki Lee; Dooyoung Jung; Ji-Won Hur; Heon-Jeong Lee; Sungkil Lee; Gerard J Kim; Chung-Yean Cho; Seungmoon Choi; Seung-Moo Lee; Chul-Hyun Cho
Journal:  J Med Internet Res       Date:  2020-10-06       Impact factor: 5.428

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.